94 related articles for article (PubMed ID: 24720)
1. Neuroleptic interaction with the serotoninergic-dopaminergic mechanisms in the nucleus accumbens.
Costall B; Naylor RJ
J Pharm Pharmacol; 1978 Apr; 30(4):257-9. PubMed ID: 24720
[No Abstract] [Full Text] [Related]
2. Injections of dopaminergic, cholinergic, serotoninergic and GABAergic drugs into the nucleus accumbens: effects on locomotor activity in the rat.
Jones DL; Mogenson GJ; Wu M
Neuropharmacology; 1981 Jan; 20(1):29-37. PubMed ID: 6261181
[No Abstract] [Full Text] [Related]
3. Cholinergic potentiation of neuroleptic effects in the nucleus accumbens.
Vance MA; Blumberg JB
Res Commun Chem Pathol Pharmacol; 1983 May; 40(2):345-8. PubMed ID: 6136070
[TBL] [Abstract][Full Text] [Related]
4. Neuroleptic antagonism of the motor inhibitory effects of apomorphine within the nucleus accumbens: drug interaction at presynaptic receptors?
Costall B; Fortune DH; Hui SC; Naylor RJ
Eur J Pharmacol; 1980 May; 63(4):347-58. PubMed ID: 6104603
[No Abstract] [Full Text] [Related]
5. Influence of antipsychotics on presynaptic receptors modulating the release of dopamine in synaptosomes of the nucleus accumbens of rats.
Hetey L; Drescher K
Neuropharmacology; 1986 Oct; 25(10):1103-9. PubMed ID: 2878387
[TBL] [Abstract][Full Text] [Related]
6. Effects of microinjection of 2-chloro-11 (2-dimethylaminoethoxy)-dibenzo[b,f]-thiepine (zotepine), thioridazine and haloperidol into the striatum and nucleus accumbens on stereotypic behaviour and motor activity.
Lai H; Carino MA; Sperry R; Horita A
J Pharm Pharmacol; 1981 Apr; 33(4):252-4. PubMed ID: 6115914
[No Abstract] [Full Text] [Related]
7. [Influence of monoamines on the dl-tetrahydropalmatine-induced inhibition of single-unit activity in the nucleus accumbens].
Liu GQ; Wu HQ; Xie L; Mei XY
Yao Xue Xue Bao; 1985 Jul; 20(7):500-4. PubMed ID: 2869636
[No Abstract] [Full Text] [Related]
8. The importance of serotonergic mechanisms for the induction of hyperactivity by amphetamine and its antagonism by intra-accumbens (3,4-dihydroxy-phenylamino)-2-imidazoline (DPI).
Costall B; Hui SC; Naylor RJ
Neuropharmacology; 1979 Jul; 18(7):605-9. PubMed ID: 492482
[No Abstract] [Full Text] [Related]
9. Behavioral interaction between endogenous opioids, CCK-8 and dopaminergic systems in the nucleus accumbens of rats.
van Ree JM; Igarashi J; Király I
NIDA Res Monogr; 1986; 75():323-6. PubMed ID: 2448632
[TBL] [Abstract][Full Text] [Related]
10. Long-term consequences of antagonism by neuroleptics of behavioural events occurring during mesolimbic dopamine infusion.
Costall B; Domeney AM; Naylor RJ
Neuropharmacology; 1984 Mar; 23(3):287-94. PubMed ID: 6145111
[TBL] [Abstract][Full Text] [Related]
11. Interactions of cholecystokinin octapeptide and dopamine on nucleus accumbens neurons.
White FJ; Wang RY
Brain Res; 1984 May; 300(1):161-6. PubMed ID: 6145498
[TBL] [Abstract][Full Text] [Related]
12. Association of the mesencephalic locomotor region with locomotor activity induced by injections of amphetamine into the nucleus accumbens.
Brudzyński SM; Mogenson GJ
Brain Res; 1985 May; 334(1):77-84. PubMed ID: 2986781
[TBL] [Abstract][Full Text] [Related]
13. Injection of low doses of apomorphine into the nucleus accumbens of rats reduces locomotor activity.
Van Ree JM; Wolterink G
Eur J Pharmacol; 1981 Jun; 72(1):107-11. PubMed ID: 7262189
[No Abstract] [Full Text] [Related]
14. 6-hydroxydopamine treatments enhance behavioral responses to intracerebral microinjection of D1- and D2-dopamine agonists into nucleus accumbens and striatum without changing dopamine antagonist binding.
Breese GR; Duncan GE; Napier TC; Bondy SC; Iorio LC; Mueller RA
J Pharmacol Exp Ther; 1987 Jan; 240(1):167-76. PubMed ID: 3100767
[TBL] [Abstract][Full Text] [Related]
15. Cholecystokinin potentiation of dopamine-mediated behaviors in the nucleus accumbens.
Crawley JN
Ann N Y Acad Sci; 1985; 448():283-92. PubMed ID: 3861122
[No Abstract] [Full Text] [Related]
16. [Effect of the atypical neuroleptics carbidine and sulpiride on dopamine biosynthesis in the synaptosomes of the nucleus accumbens septi in rats].
Kudrin VS; Hetey L; Morgenshtern R; Raevskiĭ KS; Olssner W
Farmakol Toksikol; 1987; 50(2):16-20. PubMed ID: 2884129
[TBL] [Abstract][Full Text] [Related]
17. The influence of antiserotonergic agents on the action of dopaminergic drugs.
Mogilnicka E; Scheel-Krüger J; Klimek V; Golembiowska-Nikitin K
Pol J Pharmacol Pharm; 1977; 29(1):31-8. PubMed ID: 140371
[TBL] [Abstract][Full Text] [Related]
18. Chronic treatment with classical and atypical antipsychotic drugs differentially decreases dopamine release in striatum and nucleus accumbens in vivo.
Blaha CD; Lane RF
Neurosci Lett; 1987 Jul; 78(2):199-204. PubMed ID: 2888060
[TBL] [Abstract][Full Text] [Related]
19. The cholecystokinin analogue, caerulein, does not modulate dopamine release or dopamine-induced locomotor activity in the nucleus accumbens of rat.
Hamilton M; Sheehan MJ; De Belleroche J; Herberg LJ
Neurosci Lett; 1984 Jan; 44(1):77-82. PubMed ID: 6717857
[TBL] [Abstract][Full Text] [Related]
20. Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats.
Di Chiara G; Imperato A
Proc Natl Acad Sci U S A; 1988 Jul; 85(14):5274-8. PubMed ID: 2899326
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
